newsfilter
← Latest News
PR Newswire·

Emmaus Life Sciences Provides Interim Shipment Data

TORRANCE, Calif., April 3, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX:EMMA), a leader in sickle ell disease treatment, announced today preliminary results for the 3 months ended March 31, 2023.